Abstract:Abnormal expression of the transcription factor Y-box-binding protein-1 (YBX1) is associated with the proliferation, migration, aggressiveness, and stem-like properties of various cancers. These characteristics contribute to the tumorigenesis and metastasis of cancer. We found that the expression levels of Mucin-1 (MUC1) and YBX1 were positively correlated in lung adenocarcinoma cells and lung adenocarcinoma tissue. Our retrospective cohort study of 176 lung adenocarcinoma patients after surgery showed that low expression of both YBX1 and MUC1 was an independent predictor of the prognosis and recurrence of lung adenocarcinoma. In lung adenocarcinoma cells, the silencing/overexpression of YBX1 caused a simultaneous change in MUC1, and MUC1 overexpression partially reversed the decreased tumor cell migration, aggressiveness, and stemness caused by YBX1 silencing. Moreover, chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays proved that MUC1 was the downstream target of YBX1 and that YBX1 bound to the -1480~-1476 position in the promoter region of MUC1 to regulate its transcription. Furthermore, in mouse xenograft models and a lung cancer metastasis model, MUC1, which is downstream of YBX1, partially reversed the decreased number and size of tumors caused by YBX1 silencing. In conclusion, our findings indicated a novel mechanism by which YBX1 promotes the stemness and metastasis of lung adenocarcinoma by targeting MUC1 and provided a combination approach for diagnosis different from traditional single tumor biomarkers to predict patient prognosis and provide clinical treatment targets.

Effect of Y-box binding protein 1 on tumor and its research

[Functions of Y-box Binding Protein and Its Role in Tumorigenicity].

The Roles and Mechanisms of YTH Domain-Containing Proteins in Cancer Development and Progression.

Potential Therapeutic Strategies for Targeting Y-Box-Binding Protein 1 in Cancers

Effect and Mechanism of YB-1 Knockdown on Glioma Cell Growth, Migration, and Apoptosis.

YB1 and its role in osteosarcoma: a review

Effects of Y Box Binding Protein-1 in Progression and Prognosis of Cholangiocarcinoma.

Knockdown of Y‑box‑binding protein‑1 inhibits the malignant progression of HT‑29 colorectal adenocarcinoma cells by reversing epithelial‑mesenchymal transition.

YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level

YB-1 Protein in Breast Cancer (Scientific and Personal Meetings with Professor Ovchinnikov)

Effect of Y-box binding protein-1 gene on proliferation,apoptosis and invasion ability of human breast cancer MDA-MB-231 cells

YB-1, a New Biomarker of Glioma Progression, is Associated with the Prognosis of Glioma Patients.

Research Advances in Functions of YB1 in Tumorigenesis and Tumor Progression

Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer

Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential

YBX1 Enhances Metastasis and Stemness by Transcriptionally Regulating MUC1 in Lung Adenocarcinoma

Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway

YB-1 is a Positive Regulator of KLF5 Transcription Factor in Basal-Like Breast Cancer

YB-1 Regulates Tumor Growth by Promoting MACC1/c-Met Pathway in Human Lung Adenocarcinoma

THE INFLUENCE AND REGULATORY MECHANISM OF Y-BOX BINDING PROTEIN 1 IN OSTEOSARCOMA AND ITS SIGNIFICANCE.

Elevated nuclear YBX1 expression and the clinicopathological characteristics of patients with solid tumors: a meta-analysis.